SEARCH RESULTS FOR: 得克萨斯A(72210 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

The Heart Sync Sterile Adult Radio Transparent Multi Function Electrodes are indicated for use in external pacing, defibrillation and monitoring applications as a sterile, disposable device for single patient use only. The electrodes provide the conductive interface between the defibrillator and/or the external transcutaneous (noninvasive) cardiac pacemaker and the patient's skin. The electrode is intended for use on adult patients (>22lbs/10kg). When a patient requires defibrillation, cardioversion or external pacing, these electrodes will be applied to the patient and connected to the instrument. This device is intended for use on defibrillators whose output is classified as low power (360 joule maximum). Compatible with Physio Control quik combo® adapted models of monophasic and bi-phasic defibrillators.
HEART SYNC INC
Sterile-C100-Physio
Not in Commercial Distribution

  • 10868866000018 ()
  • 00868866000011 ()
Sterile-C100-Physio

  • Electrode conductive skin pad, single-use
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
FIDIA FARMACEUTICI SPA
89122-0724-20
Not in Commercial Distribution

  • M71389122072420A1 ()
89122-0724-20

  • Synovial fluid supplementation medium
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
FIDIA FARMACEUTICI SPA
89122-0724-12
In Commercial Distribution

89122-0724-12

  • Synovial fluid supplementation medium
Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
FIDIA FARMACEUTICI SPA
89122-0724-12
Not in Commercial Distribution

  • M71389122072412A1 ()
89122-0724-12

  • Synovial fluid supplementation medium
XACT™ Carotid Stent System 10.0 mm x 20 mm Straight
ABBOTT VASCULAR INC.
82099-01
In Commercial Distribution

  • 08717648010354 ()
82099-01

  • Bare-metal carotid artery stent
XACT™ Carotid Stent System 10.0 mm x 30 mm Straight
ABBOTT VASCULAR INC.
82098-01
In Commercial Distribution

  • 08717648010347 ()
82098-01

  • Bare-metal carotid artery stent
XACT™ Carotid Stent System 10.0 mm x 30 mm Tapered
ABBOTT VASCULAR INC.
82097-01
In Commercial Distribution

  • 08717648010330 ()
82097-01

  • Bare-metal carotid artery stent
XACT™ Carotid Stent System 10.0 mm x 40 mm Tapered
ABBOTT VASCULAR INC.
82096-01
In Commercial Distribution

  • 08717648010323 ()
82096-01

  • Bare-metal carotid artery stent
XACT™ Carotid Stent System 7.0 mm x 20 mm Straight
ABBOTT VASCULAR INC.
82095-01
In Commercial Distribution

  • 08717648010316 ()
82095-01

  • Bare-metal carotid artery stent
XACT™ Carotid Stent System 7.0 mm x 30 mm Straight
ABBOTT VASCULAR INC.
82094-01
In Commercial Distribution

  • 08717648010309 ()
82094-01

  • Bare-metal carotid artery stent
< 1 ... 370 371 372 373 374 ... 1000 >